Synducin mediated modulation of tissue repair

Details Synducin mediated modulation of tissue repair Synducin mediated modulation of tissue repair

1996-10-10

1999-01-26

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, A61K 3800, A61K 3802, C07K 500, C07K 700

Patent

active

058638970

ABSTRACT:
The membrane permeating antibacterial peptide, PR-39, previously found only in the intestine, was purified from wound fluid and shown to possess syndecan-1 and syndecan-4 inductive activity specifically in mesenchymal cells. This is a newly recognized function that defines peptide containing syndecan-inducing activity, and that are known as synducins. Therefore a molecule with both antimicrobial and synducin activities is deposited in wounds where it can simultaneously reduce infection and influence the action of growth factors, matrix components, and other cellular effectors involved in wound repair. Synducins, including PR-39, and derivatives thereof, is therefore useful in the modulation of wound healing, as well as other disorders involving mesenchymal cells and cell surface molecular interaction, including metastatic disease, angiogenesis, restenosis, stasis or decubitis ulcers, and prevention of keloids.

REFERENCES:
patent: 5654273 (1997-08-01), Gallo et al.

Affiliated with

Also associated with

Rating

Synducin mediated modulation of tissue repair does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synducin mediated modulation of tissue repair, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synducin mediated modulation of tissue repair will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1450491